These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 17763414

  • 1. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
    Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ.
    Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
    [Abstract] [Full Text] [Related]

  • 2. Rituximab in the treatment of dermatomyositis: an open-label pilot study.
    Levine TD.
    Arthritis Rheum; 2005 Feb; 52(2):601-7. PubMed ID: 15692974
    [Abstract] [Full Text] [Related]

  • 3. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.
    J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
    [Abstract] [Full Text] [Related]

  • 4. A pilot trial of rituximab in the treatment of patients with dermatomyositis.
    Chung L, Genovese MC, Fiorentino DF.
    Arch Dermatol; 2007 Jun; 143(6):763-7. PubMed ID: 17576943
    [Abstract] [Full Text] [Related]

  • 5. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH, Hausner-Sypek DL, Weinblatt ME.
    J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
    [Abstract] [Full Text] [Related]

  • 6. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A.
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case].
    Yáñez V J, Cisternas M M, Saldías H V, Saldías P F.
    Rev Med Chil; 2009 Jan; 137(1):88-93. PubMed ID: 19399327
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN, Cameron B, Spiegel L, Schneider R, Laxer RM, Silverman ED, Feldman BM.
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
    Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC, RIM Study Group, Oddis CV.
    Arthritis Rheumatol; 2014 Mar; 66(3):740-9. PubMed ID: 24574235
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.
    Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, Salisbury S, Bean JA.
    Arthritis Rheum; 2007 Oct 15; 57(7):1183-91. PubMed ID: 17907236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.